Status:

WITHDRAWN

Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma

Lead Sponsor:

Indiana University

Conditions:

Anemia, Iron Deficiency

Melanoma

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Anemia is a common complication among cancer patients and is negatively associated with overall prognosis and therapeutic outcomes. The purpose of this study is to see if giving a dose of iron prior t...

Detailed Description

This is a pilot single arm, non-randomized study involving adult patients with melanoma receiving standard of care treatment with hemoglobin levels less than 13 g/dl, ferritin levels below 100 ng/ml, ...

Eligibility Criteria

Inclusion

  • ≥ 18 years old adults at the time of informed consent
  • Ability to provide written informed consent and HIPAA authorization
  • Biopsy confirmed melanoma
  • Eligible for standard of care treatment
  • Plan to undergo immunotherapy in neoadjuvant or metastatic setting
  • ECOG performance status 0-2
  • Anemia defined as hemoglobin \< 13 g/dl in addition to ferritin \< 100 ng/ml and/or transferrin saturation \< 30%

Exclusion

  • History of anaphylactic reaction to intravenous iron or any proposed standard of care treatments
  • Diagnosis of hemoglobinopathies
  • Therapeutic Iron supplementation in the past 3 months (oral iron as part of MVI allowed)
  • Diagnosis of hemochromatosis
  • Symptomatic brain metastases that require local treatment (brain metastasis which will be treated with systemic immunotherapy or treated metastasis with without need for steroids for symptomatic management are eligible).
  • Pregnant or lactating female adults
  • Active infections which in research teams' opinion increases risk for toxicities
  • Any condition that in the opinion of PI may interfere with patient being able to complete the required procedures.

Key Trial Info

Start Date :

May 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2026

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT06508827

Start Date

May 1 2025

End Date

June 1 2026

Last Update

July 9 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.